Physician profile
Gregory Stevens
NPI 1063752269
$3,090.03
in general payments reported to CMS, 2019-2025
10 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $317 · 2022: $868 · 2023: $955 · 2024: $696 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,673.54 | 2021-2024 | Senza |
| Medtronic, INC. | $792.10 | 2022-2025 | Intellis Adaptivestim, Accurian, Vanta Adaptivestim |
| Abbott Laboratories | $232.14 | 2021-2024 | Eterna, Proclaim |
| Boston Scientific Corporation | $148.74 | 2025 | General - Pain Management |
| Nalu Medical, INC. | $72.39 | 2024 | Nalu Neurostimulation System |
| Globus Medical, INC. | $63.25 | 2025 | Senza |
| Averitas Pharma INC. | $39.72 | 2023-2024 | Qutenza |
| Abbvie INC. | $24.54 | 2022 | |
| Painteq LLC | $22.85 | 2023 | Painteq |
| Spr Therapeutics, INC | $20.76 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.